Chief Operating Officer, EMEA

Ms. Defraiteur has over 20 years’ experience in the life science and radiochemistry industries. Caroline joined Telix as part of the acquisition of Advanced Nuclear Medicine Ingredients (ANMI) in 2018, where she oversaw product development of the Illuccix kit. At Telix, she was appointed General Manager of Telix’s operations in Liege, Belgium, responsible for quality assurance and delivery of 68Ga-PSMA-11 kits.

Prior to joining Telix, Caroline worked at General Electric (GE) where she led the Chemistry Development team and supported the commercial launch of a radiochemistry platform and on-demand tracer production.

Caroline holds a PhD in Radiochemistry and Organic Synthesis from the Cyclotron Research Center, Liege University.